NHL Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular Lymphoma
Recruiting
  • Follicular Lymphoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies
Recruiting
  • Follicular Lymphoma
  • +3 more
  • CD22-CAR
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
N
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Recruiting
  • Non-Hodgkin's Lymphoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
S
A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients
Active, not recruiting
  • NHL
  • No intervention
  • Alkmaar, Netherlands
  • +59 more
2022-03-22
Mar 22, 2022
S
A Study of IGN002 for Refractory NHL
Withdrawn
  • NHL
  • IGN002
  • Santa Monica, California
    UCLA
2022-02-23
Feb 23, 2022
H
HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL
Recruiting
  • CLL/SLL
  • +8 more
  • Atlanta, Georgia
  • +3 more
2022-02-24
Feb 24, 2022
S
The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
Active, not recruiting
  • NHL
  • DLBCL
  • Antwerpen, Belgium
  • +31 more
2022-01-19
Jan 19, 2022
M
FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
Recruiting
  • NHL
  • +3 more
  • Minneapolis, Minnesota
  • +1 more
2022-01-03
Jan 3, 2022
A
Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies - 2019
Terminated
  • Multiple Myeloma
  • +6 more
  • AMG 397
  • +2 more
  • Birmingham, Alabama
  • +20 more
2021-12-20
Dec 20, 2021
S
First-in Human (FIH) Trial of ETH-155008 in Subjects With B-NHL, CLL/SLL and AML
Recruiting
  • NHL
  • Leukemia
  • Adelaide, South Australia, Australia
  • +3 more
2021-09-27
Sep 27, 2021
G
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - 2017
Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
2021-08-12
Aug 12, 2021
G
Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL - 2013
Completed
  • NHL
  • +17 more
  • veltuzumab
  • Savannah, Georgia
  • +4 more
2021-08-12
Aug 12, 2021
G
Safety Study of NHL With 90Y-hLL2 IgG - 2007
Completed
  • NHL
  • +2 more
  • 90Y-hLL2
  • Nantes, Cedex, France
  • +4 more
2021-08-12
Aug 12, 2021
K
PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA) - 2021
Terminated
  • Solid Tumors
  • NHL
  • Los Angeles, California
  • +7 more
2021-06-22
Jun 22, 2021
A
Platform Study for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma (PRISM Study) - 2021
Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
2021-04-28
Apr 28, 2021
U
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
Recruiting
  • AML
  • +4 more
  • Hyperbaric oxygen
  • Rochester, New York
    University of Rochester
2021-04-05
Apr 5, 2021
B
Assessment of Safety and Efficacy of IM19 for Recurrent or Refractory (R/R) Non-Hodgkin's Lymphoma(NHL) Patients
Recruiting
  • NHL
  • IM19 CAR-T Cells
  • Beijing, Beijing, China
    Beijing Cancer Hospital
2020-12-04
Dec 4, 2020
X
Anti-CD19 CAR NK Cell Therapy for R/R Non-Hodgkin Lymphoma.
Not yet recruiting
  • NHL
  • anti-CD19 CAR NK
  • ChongQing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
2020-11-19
Nov 19, 2020
N
Influence of Corn Farming on the Immune System - 2008
Completed
  • NHL
    • Iowa City, Iowa
      University of Iowa
    2020-09-08
    Sep 8, 2020
    S
    Allogeneic Transplantation From Related Haploidentical Donors - 2010
    Completed
    Has Results
    • Blood Cancer
    • +7 more
    • non-myeloablative hematopoietic cell transplantation
    • +8 more
    • Stanford, California
      Stanford University School of Medicine
    2019-11-17
    Nov 17, 2019
    B
    Safety and Efficacy Evaluation of Decitabine With R-GDP
    Unknown status
    • NHL
    • Decitabine and R-GDP
    • Peking, Beijing, China
      Peking university third hospital
    2018-05-14
    May 14, 2018
    D
    Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma - 2016
    Terminated
    • Solid Tumors
    • +5 more
    • Stanford, California
    • +5 more
    2017-12-13
    Dec 13, 2017
    U
    Umbilical Cord Blood Transplant for Hematological Malignancies - 2016
    Completed
    • CML
    • +6 more
    • Ex Vivo CD3/CD28 costimulated Umbilical Cord Blood T cells
    • Observation Arm
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    2016-08-17
    Aug 17, 2016
    D
    Myeloablative Allogeneic Stem Cell Transplantation Using a Naive T-Cell Depleted Peripheral Blood Stem Cell Graft - 2013
    Terminated
    Has Results
    • ALL
    • +3 more
    • Naive T-cell Depleted Stem Cell Transplant
    • +2 more
    • (no location specified)
    2013-09-25
    Sep 25, 2013
    U
    Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia - 2007
    Completed
    • Acute Myeloid Leukemia
    • +10 more
      • San Francisco, California
        University of California San Francisco
      2012-11-07
      Nov 7, 2012